PCSA
PCSA
NASDAQ · Pharmaceuticals

Processa Pharmaceuticals Inc

$2.41
+0.08 (+3.43%)
As of Mar 25, 5:55 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,431.1% upside
Low Target $23.79
Average Target $36.90
High Target $41.20
Current Price $2.41
Current
$2.41
Target
$36.90
$23.79 $36.90 avg $41.20
Scenario Analysis
Bear Case
$23.79
887.1%
Low target
Base Case
$36.90
+1,431.1%
Avg target
Bull Case
$41.20
+1,609.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$19.63
-87.7% from high
52-Week Low
$1.76
+36.9% from low
Target vs 52W High
$36.90
+88.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%